Stay updated on Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.

Latest updates to the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5. This indicates a minor update to the page’s revision metadata rather than substantive content changes.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a minor site version update. This change reflects maintenance of the page version rather than any modification to trial content or functionality.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This reflects a minor maintenance update to the page without changes to the study information or its presentation.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision tag is updated to v3.6.2, reflecting a new version. The previous v3.6.0 tag was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now displays the recruitment status 'No longer looking for participants' and adds new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). The 'Intervention / Treatment' label has been updated to 'Intervention/Treatment' and the revision tag updated to v3.6.0.SummaryDifference0.5%

- Check72 days agoChange DetectedThe revision indicator on the page updated from v3.5.4 to v3.5.5, signaling a minor update to the version history rather than a change to study content.SummaryDifference0.1%

Stay in the know with updates to Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.